PGNY (Progyny, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by PGNY officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-16 | Melissa B Cummings | Chief Operating Officer | MIXED | — | — |
| 2026-06-23 | Geoffrey Clapp | Chief Product Officer | F | — | — |
| 2026-06-05 | Peter Anevski | CHIEF EXECUTIVE OFFICER | F | — | — |
| 2026-06-05 | Allison Swartz | EVP, GC | MIXED | — | — |
| 2026-06-05 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2026-06-03 | Geoffrey Clapp | Chief Product Officer | MIXED | — | — |
| 2026-06-03 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2026-06-03 | Cheryl Scott | Director | MIXED | — | — |
| 2026-06-01 | Allison Swartz | EVP, GC | MIXED | — | — |
| 2026-05-29 | KEVIN K GORDON | Director | MIXED | — | — |
| 2026-05-26 | ROGER C HOLSTEIN | Director | A | — | — |
| 2026-05-26 | KEVIN K GORDON | Director | A | — | — |
| 2026-05-26 | Lloyd H Dean | Director | A | — | — |
| 2026-05-26 | Norman Payson | Director | A | — | — |
| 2026-05-26 | DEBRA L MORRIS | Director | A | — | — |
| 2026-05-26 | Jeffrey G Park | Director | A | — | — |
| 2026-05-26 | Cheryl Scott | Director | A | — | — |
| 2026-05-26 | Elizabeth D Bierbower | Director | A | — | — |
| 2026-05-21 | Melissa B Cummings | Chief Operating Officer | Sell | — | — |
| 2026-05-21 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | Sell | — | — |
| 2026-04-16 | Melissa B Cummings | Chief Operating Officer | F | — | — |
| 2026-03-19 | Geoffrey Clapp | Chief Product Officer | F | — | — |
| 2026-03-06 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | F | — | — |
| 2026-03-06 | Allison Swartz | EVP, GC | MIXED | — | — |
| 2026-03-04 | Melissa B Cummings | Chief Operating Officer | A | — | — |
| 2026-03-04 | Geoffrey Clapp | Chief Product Officer | A | — | — |
| 2026-03-04 | Peter Anevski | CHIEF EXECUTIVE OFFICER | MIXED | — | — |
| 2026-03-04 | Allison Swartz | EVP, GC | MIXED | — | — |
| 2026-03-04 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2026-01-05 | Peter Anevski | CHIEF EXECUTIVE OFFICER | F | — | — |
| 2026-01-05 | David J Schlanger | Executive Chairman | F | — | — |
| 2026-01-05 | Michael E Sturmer | PRESIDENT | F | — | — |
| 2025-12-15 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | Sell | — | — |
| 2025-12-08 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | F | — | — |
| 2025-12-08 | Michael E Sturmer | PRESIDENT | F | — | — |
| 2025-12-08 | Allison Swartz | EVP, GC | MIXED | — | — |
| 2025-12-04 | Michael E Sturmer | PRESIDENT | F | — | — |
| 2025-12-04 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | MIXED | — | — |
| 2025-12-02 | Allison Swartz | EVP, GC | MIXED | — | — |
| 2025-11-19 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | Sell | — | — |
| 2025-11-18 | Norman Payson | Director | MIXED | — | — |
| 2025-11-17 | Peter Anevski | CHIEF EXECUTIVE OFFICER | Buy | — | — |
| 2025-11-13 | David J Schlanger | Executive Chairman | MIXED | — | — |
| 2025-11-13 | Peter Anevski | CHIEF EXECUTIVE OFFICER | MIXED | — | — |
| 2025-10-02 | David J Schlanger | Executive Chairman | F | — | — |
| 2025-10-02 | Peter Anevski | CHIEF EXECUTIVE OFFICER | F | — | — |
| 2025-09-05 | Mark S. Livingston | CHIEF FINANCIAL OFFICER | F | — | — |
| 2025-09-05 | Michael E Sturmer | PRESIDENT | F | — | — |
| 2025-09-05 | Allison Swartz | EVP, GC | MIXED | — | — |
| 2025-09-03 | Michael E Sturmer | PRESIDENT | F | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 14,725,118 | — |
| — | 10%+ Owner | 11,447,471 | — |
| — | 10%+ Owner | 10,000,000 | — |
| — | 10%+ Owner | 9,250,000 | — |
| — | 10%+ Owner | 8,823,142 | — |
| — | 10%+ Owner | 7,873,530 | — |
| — | — | 6,350,000 | — |
| — | 10%+ Owner | 6,238,244 | — |
| — | EVP, Chief of Strategic Dev. | 1,085,513 | — |
| — | CHIEF EXECUTIVE OFFICER | 811,473 | — |
| — | Director | 271,322 | — |
| — | PRESIDENT | 255,205 | — |
| — | Executive Chairman | 245,356 | — |
| — | Director | 134,842 | — |
| — | EVP, GENERAL COUNSEL | 103,237 | — |
| — | EVP, GC | 84,515 | — |
| — | CHIEF FINANCIAL OFFICER | 74,688 | — |
| — | Chief Operating Officer | 69,934 | — |
| — | Chief Product Officer | 59,828 | — |
| — | Director | 39,981 | — |
| — | Director | 34,439 | — |
| — | Director | 28,729 | — |
| — | Director | 26,519 | — |
| — | Director | 22,693 | — |
| — | Director | 21,819 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the PGNY quote page; the site-wide leaderboard is on the insider transactions hub.